HER2-positive Locally Advanced Resectable Gastric Cancer
1 clinical trials · Condition
◉ Watch HER2-positive Locally Advanced Resectable Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC (NCT06023758) | Peking University | 2023-09-22 |
Track HER2-positive Locally Advanced Resectable Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.